Fierce Pharma April 19, 2024
Immunology is AbbVie’s world, everyone else just lives in it. That is the takeaway from ZoomRx’s analysis of the perceptions of healthcare professionals (HCPs), who overwhelmingly see AbbVie as the top dog in a field targeted by rivals such as Pfizer and Johnson & Johnson.
ZoomRx asked HCPs to rank immunology drug developers in terms of attributes such as innovation and patient centricity. Most HCPs ranked AbbVie as one of the top three companies in each category, causing it to score 100 on ZoomRx’s perception scale. Pfizer was a distant second with a score of 70, followed by J&J with a score of 52.
AbbVie was a dominant force in immunology throughout the Humira era. Novel and biosimilar rivals...
Today's Sponsors
Today's Sponsor